Article
Histone acetyltransferase-deficient p300 mutants in diffuse large B cell lymphoma have altered transcriptional regulatory activities and are required for optimal cell growth.
Molecular cancer - 15 Feb 2014
Haery Leila, Lugo-Picó Julián G, Henry Ryan A, Andrews Andrew J, Gilmore Thomas D
Abstract excerpt
BACKGROUND: Recent genome-wide studies have shown that approximately 30% of diffuse large B-cell lymphoma (DLBCL) cases harbor mutations in the histone acetyltransferase (HAT) coactivators p300 or CBP. The majority of these mutations reduce or eliminate the catalytic HAT activity. We previously d...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
